Emergent BioSolutions

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EBS and other ETFs, options, and stocks.

About EBS

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. 

CEO
Joseph C. Papa
CEOJoseph C. Papa
Employees
900
Employees900
Headquarters
Gaithersburg, Maryland
HeadquartersGaithersburg, Maryland
Founded
1998
Founded1998
Employees
900
Employees900

EBS Key Statistics

Market cap
431.75M
Market cap431.75M
Price-Earnings ratio
8.87
Price-Earnings ratio8.87
Dividend yield
Dividend yield
Average volume
530.21K
Average volume530.21K
High today
$9.29
High today$9.29
Low today
$7.67
Low today$7.67
Open price
$8.96
Open price$8.96
Volume
556.60K
Volume556.60K
52 Week high
$14.06
52 Week high$14.06
52 Week low
$4.71
52 Week low$4.71

Stock Snapshot

As of today, Emergent BioSolutions(EBS) shares are valued at $8.36. The company's market cap stands at 431.75M, with a P/E ratio of 8.87.

On 2026-05-01, Emergent BioSolutions(EBS) stock traded between a low of $7.67 and a high of $9.29. Shares are currently priced at $8.36, which is +9.1% above the low and -10.0% below the high.

The Emergent BioSolutions(EBS)'s current trading volume is 556.6K, compared to an average daily volume of 530.21K.

During the past year, Emergent BioSolutions(EBS) stock moved between $4.71 at its lowest and $14.06 at its peak.

During the past year, Emergent BioSolutions(EBS) stock moved between $4.71 at its lowest and $14.06 at its peak.

EBS News

TipRanks 17h
Emergent BioSolutions Posts Weak Q1 Results Amid Turnaround

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

TipRanks 1d
Emergent BioSolutions Shareholders Back Board, Incentive Plan Changes

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

TipRanks 2d
Emergent BioSolutions enters SAB-142 development pact with SAB Biotherapeutics

Emergent BioSolutions (EBS) announced a multi-year agreement with SAB Biotherapeutics (SABS) to support the process development and manufacturing of SAB-142, SA...

People also own

Based on the portfolios of people who own EBS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.